Announcements Trials
Browse Landscape

Phase

Phase NA 5

Status

Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 3Tumor-Agnostic 1

Conditions

Neoplasms 2Brain Neoplasms 2Neurologic Manifestations 1Neuralgia 1Glioma 1

Interventions

pembrolizumab 1262Specimen Handling 924Magnetic Resonance Spectroscopy 829Carboplatin 821Cyclophosphamide 799Cisplatin 722Nivolumab 667Paclitaxel 627Radiotherapy 608Gemcitabine 570Biopsy 557Bevacizumab 478Dexamethasone 437fludarabine 407Docetaxel 377venetoclax 367Oxaliplatin 364Capecitabine 355Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 329Drug Therapy 325Doxorubicin 316Radiosurgery 314Standard of Care 309Blood Specimen Collection 308Pemetrexed 304Ipilimumab 298Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Transcranial Magnetic Stimulation × 1 year × Clear all
NCT07530536 2026-04-15

rTMS for Postoperative Brain Tumor Patients

Columbia University

Phase NA Recruiting
6 enrolled
CNS

Brain Neoplasms, Neurologic Manifestations

NCT03606161 2026-02-19

Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors

M.D. Anderson Cancer Center

Phase NA Active not recruiting
32 enrolled
CNS

Brain Neoplasms

NCT07285525 2025-12-16

Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS

Beijing Neurosurgical Institute

Phase NA Active not recruiting
43 enrolled
CNS

Glioma

NCT03219502 2025-10-14

rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
56 enrolled
Tumor-Agnostic

Neoplasms

NCT07187219 2025-09-22

NeuroCanPain

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Recruiting
60 enrolled

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡